Literature DB >> 31403542

How We Do It: Administration Guide for Intralesional Immunotherapy With Talimogene Laherparepvec (T-VEC) for Advanced Melanoma.

Dawn Queen1, Faramarz H Samie2, Nathalie C Zeitouni3.   

Abstract

Entities:  

Year:  2020        PMID： 31403542     DOI： 10.1097/DSS.0000000000002098

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN： 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  1 in total

Review 1.  Talimogene Laherparepvec in Non-Melanoma Cancers.

Authors:  Antoine Salloum; Jenna Koblinski; Nagham Bazzi; Nathalie C Zeitouni
Journal:  J Clin Aesthet Dermatol       Date:  2021-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.